Warby Parker (WRBY) Cash from Financing Activities (2020 - 2026)
Warby Parker (WRBY) posted Cash from Financing Activities of -$6.2 million for Q1 2026, down 166.21% on a QoQ basis from -$2.3 million in Q4 2025, and down 167.59% year-over-year from $9.1 million in Q1 2025.
Warby Parker (WRBY) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Warby Parker's Cash from Financing Activities history runs 7 years deep, the most recent figure standing at -$6.2 million for Q1 2026.
- Quarterly Cash from Financing Activities fell 167.59% year-over-year to -$6.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$15.9 million (down 717.89% YoY) and the FY2025 annual result came in at -$12.0 million, down 341.92% from the prior year.
- Cash from Financing Activities was -$6.2 million for Q1 2026 at Warby Parker, down from -$2.3 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $3.6 million in Q2 2024 and bottomed at -$6.2 million in Q1 2026.
- A 5-year average of -$413882.4 and a median of $112000.0 in 2022 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities jumped 108.45% — and 2025, when it sank 9904.26%.
- Warby Parker's Cash from Financing Activities stood at $1.2 million in 2022, then slumped by 39.01% to $730000.0 in 2023, then surged by 65.07% to $1.2 million in 2024, then plunged by 292.03% to -$2.3 million in 2025, then sank by 166.21% to -$6.2 million in 2026.
- Business Quant data shows WRBY's Cash from Financing Activities at -$6.2 million in Q1 2026, -$2.3 million in Q4 2025, and -$4.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -133.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -414.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -13.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -255.24 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -50.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -48.13 Mn |
| 10 | Warby Parker | 3.00 Bn | 2.71 Bn | 131.04 Mn | -6.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.16 Mn |
| Mar 31, 2026 | -6.16 Mn |
| Dec 31, 2025 | -2.31 Mn |
| Dec 31, 2025 | -2.31 Mn |
| Sep 30, 2025 | -4.61 Mn |
| Sep 30, 2025 | -4.61 Mn |
| Jun 30, 2025 | -2.77 Mn |
| Jun 30, 2025 | -2.77 Mn |
| Mar 31, 2025 | -2.30 Mn |
| Mar 31, 2025 | -2.30 Mn |
| Dec 31, 2024 | 1.21 Mn |
| Dec 31, 2024 | 1.21 Mn |
| Sep 30, 2024 | 47,000.00 |
| Sep 30, 2024 | 47,000.00 |
| Jun 30, 2024 | 3.62 Mn |
| Jun 30, 2024 | 3.62 Mn |
| Mar 31, 2024 | 91,000.00 |
| Mar 31, 2024 | 91,000.00 |
| Dec 31, 2023 | 730,000.00 |
| Dec 31, 2023 | 730,000.00 |